Menu

Press Releases and Bulletins

DEADLINE April 26, 2019 - The ASRM Research Institute Solicits its First Round of Major Grant Applications

The newly established ASRM Research Institute invites applications from investigators to develop research projects addressing fundamental questions of major clinical significance to reproductive medicine. Preference for funding will be given to projects that attempt to answer timely, basic and clinically relevant questions of potential high impact to the practice of reproductive medicine and which are currently not fundable (either because of applicable existing federal law or because of relatively lower prioritization) by federal funding agencies. Applicants are advised to review the recently published ASRM Research Blueprint identifying the list of research priorities for the Society.

ASRM Goes to Geneva for the World Health Organization’s Global Summit on Safety and Access to Fertility Care

This week, members of ASRM’s leadership team are meeting with other leaders in reproductive health from around the world in Geneva, Switzerland. The WHO is holding its Global Summit on Safety and Access to Fertility Care to develop strategies for improving access to safe, ethical, and cost-effective fertility care, particularly in developing countries. This conference follows up on an ASRM-sponsored meeting in 2015.

ASRM Statement on Reports of Human Reproductive Gene-Editing in China

Statement attributable to ASRM President, Peter Schlegel, MD.

 

“We have reviewed the report of He Jiankui of Shanghai, China, regarding the initiation of a twin pregnancy after premature human application of the unfolding scientific technique of CRISPER/Cas to modify genes in human embryos as part of an in vitro fertilization (IVF) procedure.  Although gene editing may have an important place in human medicine in the future, it should only be used clinically after careful study done with vigorous oversight. 

Men Diagnosed with Azoospermia Are at Increased Risk of Death

Denver, CO-  Today, Scandinavian and American researchers presented the outcomes of a large prospective cohort study, looking at the connection between mortality risk and a diagnosis of male factor infertility.  Men diagnosed with azoospermia- no sperm observed in the ejaculate- were found to be at increased risk of dying during the years following assisted reproduction treatment compared to men with no male factor diagnosis. This risk was not seen for men with low sperm counts.

Looking for Additional Information?
Visit our provider site at asrm.org
 

Find a Health Care Provider

 

Zika